Exclusive: Clinical-Stage Specialty Pharma EyeGate CEO On Relationship With Valeant
February 23, 2017 at 15:21 PM EST
Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) entered into a licensing agreement with Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Tuesday ...